Dibucaine Cream
»Dibucaine Cream contains not less than 90.0percent and not more than 110.0percent of the labeled amount of C20H29N3O2in a suitable cream base.
Packaging and storage
Preserve in collapsible tubes or in tight,light-resistant containers.
Identification
The UVabsorption spectrum of the solution employed for measurement of absorbance in the Assayexhibits maxima and minima at the same wavelengths as that of the solution of USP Dibucaine Hydrochloride RSprepared as directed in the Assay.
Microbial limits á61ñ
It meets the requirements of the tests for absence of Staphylococcus aureusand Pseudomonas aeruginosa.
Minimum fill á755ñ:
meets the requirements.
Assay
Standard preparation
Transfer about 25mg of USP Dibucaine Hydrochloride RS,accurately weighed,to a 100-mLvolumetric flask,add 20.0mLof 0.1Nhydrochloric acid,and swirl to dissolve.Dilute with methanol to volume,and mix.Pass through a suitable filter of 0.5-µm or finer porosity.
Assay preparation
Weigh accurately a portion of Cream,equivalent to about 22mg of dibucaine,transfer to a separator containing 25mLof ether,and mix to dissolve.Extract successively with two 9-mLportions of 0.1Nhydrochloric acid,combining the extracts in a 100-mLvolumetric flask.Extract the ether phase in the separator with 2mLof water,collecting the aqueous extract in the 100-mLvolumetric flask.Dilute with methanol to volume,and mix.Pass through a suitable filter of 0.5-µm or finer porosity.
Procedure
Separately inject equal volumes (about 20µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the area responses for the major peaks.Calculate the quantity,in mg,of dibucaine (C20H29N3O2)in the portion of Cream taken by the formula:
(343.46/379.93)(100C)(rU/rS),
in which 343.46and 379.93are the molecular weights of dibucaine and dibucaine hydrochloride,respectively;Cis the concentration,in mg per mL,of USP Dibucaine Hydrochloride RSin the Standard preparation;and rUand rSare the area responses of the dibucaine peaks obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information
Staff Liaison:Karen A Russo,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28NF23Page 623
Phone Number:1-301-816-8379
|